Premium
IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY
Author(s) -
Bonnet C.M.,
Lamy T.,
Fruchart C.,
Legouill S.,
Gunzer K.,
Gastinne T.,
Jardin F.,
Karlin L.,
Houot R.,
Dupuis J.,
Tilly H.,
Salles G.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_188
Subject(s) - medicine , dhap , gastroenterology , neutropenia , mantle cell lymphoma , febrile neutropenia , nausea , mucositis , cytarabine , rash , ibrutinib , rituximab , surgery , oncology , lymphoma , toxicity , chemotherapy , leukemia , chronic lymphocytic leukemia , biochemistry , chemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom